Human

Cisco Investments and Third Culture Capital Among Notable Investors in Voiceitt’s Latest Funding Round to Scale its Accessible Speech Recognition

Retrieved on: 
Friday, December 2, 2022
Software, Audio, Video, Health, Artificial Intelligence, Health Technology, Technology, Apps, Applications, Other Technology, Disability, Veteran, Cisco Systems, BBC, Microsoft, MPH, Brain, Ministry of Women and Vulnerable Populations, AARP, Algorithm, Alexa, Arm, The New York Times, Communication, Creativity, Corporate development, ASR, Human, Degenerative disease, Social media, Partnership, Hospital, AMIT, API, IPad Air 2, Database, Speech, Machine learning, Association of British HealthTech Industries, Mobile phone, Medicine, Techstars, MD

Voiceitt , the Israel-based award-winning leader in speech recognition technology for non-standard speech, announced today the closing of its latest funding round led by AMIT Technion , with participation from Cisco Investments and Third Culture Capital (3CC).

Key Points: 
  • Voiceitt , the Israel-based award-winning leader in speech recognition technology for non-standard speech, announced today the closing of its latest funding round led by AMIT Technion , with participation from Cisco Investments and Third Culture Capital (3CC).
  • The announcement follows the momentum of the beta launch of Voiceitts next-generation technology that recognizes and translates spontaneous speech of people with speech disabilities.
  • Third Culture Capital (3CC) joins Voiceitts momentous funding round in alignment with a mission to rewire the world for the better by advancing equity and diversity in technology.
  • The proprietary automatic speech recognition (ASR) enables people with speech disabilities to access mainstream voice technologies, communicate by voice and be understood.

THE 20th ANNUAL CHICAGO TOY & GAME FAIR RESUMES IN-PERSON EVENT ON DECEMBER 10 & 11, 2022

Retrieved on: 
Friday, December 2, 2022
Giant, Fair, Parent, POP, Oxford Games, The Singing Machine Company, The Walt Disney Company, COVID, Diary, Human, Toy, Oscar, Mental, Goliath, Fashion Outlets of Chicago, Beer, Rummikub, Donald, Cutthroat (pool), MESH, Jenga, PlayMonster, Nightclub, ThinkFun, Hasbro, Mattel, Health

CHICAGO, Dec. 2, 2022 /PRNewswire-PRWeb/ -- On December 10th and 11th the 2022 Holiday Chicago Toy & Gift Fair (CHITAG), North America's largest toy & game fair open to the public, will be resuming their annual in-person event after a 2-year hiatus due to COVID. This marks the 20th year for CHITAG, which will take place at a new venue this year: the Donald J. Stephens Convention Center in Rosemont (5555 N River Rd Rosemont, IL 60018).

Key Points: 
  • CHICAGO, Dec. 2, 2022 /PRNewswire-PRWeb/ -- On December 10th and 11th the 2022 Holiday Chicago Toy & Gift Fair (CHITAG), North America's largest toy & game fair open to the public, will be resuming their annual in-person event after a 2-year hiatus due to COVID.
  • Toy giant Goliath Group will also host a qualifying event for the North American Rummikub Championship on Saturday, December 10th at CHITAG.
  • The entry fee is only $25 and includes free admission to CHITAG, plus a Rummikub Premium Edition game (combined package value $45.00).
  • "To celebrate the start of our 20th anniversary we are rolling back prices to 2003 when we first started this event.

The Solutions Brand of Optomi Professional Services Receives Veteran-Friendly Employer Award

Retrieved on: 
Friday, December 2, 2022
SOC, Veteran, Workforce, Woman, HERE, IAM, Human, Texas Workforce Commission, Spouse, Heart, Conference, NOC, HD, TWC, Partnership, Application, OPS, Head, Medicine

ATLANTA, Dec. 2, 2022 /PRNewswire/ -- Optomi Professional Services is pleased to announce that the Texas Workforce Commission (TWC) selected Provalus as the 2022 Texas Workforce Solutions Veteran-Friendly Employer of the Year from among the many nominated employers across the state. Each year, the state's 28 Local Workforce Development Boards nominate exceptional employers from their respective local workforce development areas for consideration for the Texas Workforce Solutions Employer of the Year awards. The award recognizes the innovative efforts to recruit, hire, and retain veterans as an important part of the Provalus workforce.

Key Points: 
  • As the managed services brand of Optomi Professional Services, Provalus serves Fortune-listed clients with dependable, quality and practical technology-related services while creating new jobs in rural communities.
  • The award will be presented during the 25th Annual Texas Workforce Conference Employer Awards Luncheon Thursday, December 1st.
  • Our veteran-friendly initiatives demonstrate our commitment to the country and to the military community," commented Chuck Ruggiero, Chief Executive Officer of Optomi Professional Services.
  • Optomi Professional Services is a 100% U.S.- based firm dedicated to partnering with clients to fuel critical technology initiatives.

Pure IP Launches Webex Calling Solution for PSTN Connectivity

Retrieved on: 
Friday, December 2, 2022
Cloud, Geography, Cisco Systems, Newsroom, Google Cloud Connect, PSTN, Privacy, Internet, Cisco Webex, AI, Machine learning, Human, Partnership, Language, Environment, Personality, SAN, Network equipment, Mobile phone

SAN FRANCISCO, Dec. 2, 2022 /PRNewswire/ -- Pure IP , a global provider of enterprise voice communications, is now a Certified Calling Provider through Cloud Connect for Webex by Cisco's cloud-based phone system, Webex Calling.

Key Points: 
  • SAN FRANCISCO, Dec. 2, 2022 /PRNewswire/ -- Pure IP , a global provider of enterprise voice communications, is now a Certified Calling Provider through Cloud Connect for Webex by Cisco's cloud-based phone system, Webex Calling.
  • Customers can now choose Pure IP to enable Cloud Connect for Webex Calling.
  • The program delivers PSTN connectivity with Webex Calling through a world-class selection of providers that underwent a rigorous certification process.
  • Delivered as a fully managed voice solution with 24/7 technical support and a suite of online management tools, Pure IP's solution for Webex Calling was designed specifically for the enterprise customer.

Genprex to Present at Upcoming December Investor Conference

Retrieved on: 
Friday, December 2, 2022
NSCLC, PDX1, Type 2, COVID-19, Insulin, MAF (gene), Human, Intellectual property, Pancreas, Tumor suppressor gene, Type 1, Diabetes, Large-cell lung carcinoma, Immune system, Cancer, Conference, Squamous cell carcinoma, Annual report, Risk, Growth, Q&A, Food, Food and Drug Administration Amendments Act of 2007, AAV, Protein, Autoimmunity, Patient, Security (finance), Gene, General counsel, Uncertainty, Pharmaceutical industry, Audit

AUSTIN, Texas , Dec. 2, 2022 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that its Executive Vice President, General Counsel and Chief Strategy Officer, Catherine Vaczy, will be providing an overview of the Company's gene therapies for cancer and diabetes at the following investor conference in December 2022.

Key Points: 
  • Ms. Vaczy will be available for Q&A following the presentation and for in-person one-on-one meetings with investors at the RHK Disruptive Growth Conference.
  • Genprex, Inc. is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes.
  • Genprex works with world-class institutions and collaborators to develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches.
  • You should not regard these statements as a representation or warranty by Genprex or any other person that Genprex will achieve its objectives and plans in any specified timeframe, or at all.

HR Path welcomes the Fischer Group International (FGI)

Retrieved on: 
Friday, December 2, 2022
Consultant, Human resources, HR, Digital Solutions, Implement, DACH, Acquisition, Human, Leadership development, FGI, Management

PARIS, Dec. 2, 2022 /PRNewswire/ --HR Pathwarmly welcomes FGI (Fischer Group International) into the Group which, will continue to strengthen and expand its 'Advise' business line internationally.

Key Points: 
  • PARIS, Dec. 2, 2022 /PRNewswire/ --HR Pathwarmly welcomes FGI (Fischer Group International) into the Group which, will continue to strengthen and expand its 'Advise' business line internationally.
  • HR Path, a global HR leader has been supporting companies in their digital transformation projectsaround the world for over 21 years.
  • We also welcome Carlo Fischer as a partner at HR Path becoming the Head of HR Path Germany.
  • Fischer Group International is a leading international management consultancy based in Hamburg represented internationally supporting all size of corporations for over three decades.

HR Path welcomes the Fischer Group International (FGI)

Retrieved on: 
Friday, December 2, 2022
Consultant, Human resources, HR, Digital Solutions, Implement, DACH, Acquisition, Human, Leadership development, FGI, Management

PARIS, Dec. 2, 2022 /PRNewswire/ --HR Pathwarmly welcomes FGI (Fischer Group International) into the Group which, will continue to strengthen and expand its 'Advise' business line internationally.

Key Points: 
  • PARIS, Dec. 2, 2022 /PRNewswire/ --HR Pathwarmly welcomes FGI (Fischer Group International) into the Group which, will continue to strengthen and expand its 'Advise' business line internationally.
  • HR Path, a global HR leader has been supporting companies in their digital transformation projectsaround the world for over 21 years.
  • We also welcome Carlo Fischer as a partner at HR Path becoming the Head of HR Path Germany.
  • Fischer Group International is a leading international management consultancy based in Hamburg represented internationally supporting all size of corporations for over three decades.

EQS-News: First Patients Dosed in Phase I/II Trial of Enlivex’s Off-the-Shelf Cell Therapy Candidate, AllocetraTM

Retrieved on: 
Friday, December 2, 2022
NYSE, Cell, Neoplasm, The 7 Habits of Highly Effective People, Sepsis, Survival, Lymphatic system, Skin, NVS, COGS, Safety, Human, Ministry, Probability, Weapon, Survival rate, Prognosis, Immune system, Cancer, Advertising, Immunotherapy, Annual report, Risk, MRK, Pfizer, Macrophage, Injection, FDA, Criticism of the Food and Drug Administration, Animal, Tisagenlecleucel, Marketing, Security (finance), Patient, Mortality, CAR, Pembrolizumab, Partnership, Merck, Merck & Co., Mouse, Food, Pharmaceutical industry, Vaccine, EU, Health, Phase

First Patients Dosed in Phase I/II Trial of Enlivexs Off-the-Shelf Cell Therapy Candidate, AllocetraTM

Key Points: 
  • First Patients Dosed in Phase I/II Trial of Enlivexs Off-the-Shelf Cell Therapy Candidate, AllocetraTM
    The issuer is solely responsible for the content of this announcement.
  • On November 13, Enlivex (NASDAQ: ENLV) announced that the first patient has been dosed in its Phase I/II clinical trial of Allocetra.
  • Enlivexs lead drug candidate, AllocetraTM , was developed as an off-the-shelf cell therapy that reprograms macrophages , the immune cells responsible for killing infected or harmful cells in the body.
  • The next step for this new cell therapy is to test whether these promising preclinical results will translate to human studies.

Momentus to Participate in Morgan Stanley Space Summit

Retrieved on: 
Friday, December 2, 2022
Defense, Satellite, Technology, Aerospace, Manufacturing, Military, Contracts, Seagate Technology, Microwave electrothermal thruster, MET, CubeSat, Morgan Stanley, Morgan, Annual report, Internet, Miniaturization, Security (finance), Water, Maintenance, Inc., Transport, Human, Moon, Human back, Russian Orbital Service Station, Department of Defense Manned Space Flight Support Office, Electric power industry, Communications satellite, California Institute of Technology

Momentus Inc. (NASDAQ: MNTS) (Momentus or the Company), a U.S. commercial space company that offers transportation and other in-space infrastructure services, announced that Chief Executive Officer John Rood will participate in the Morgan Stanley 5th Annual Space Summit taking place on December 6, 2022, in New York City.

Key Points: 
  • Momentus Inc. (NASDAQ: MNTS) (Momentus or the Company), a U.S. commercial space company that offers transportation and other in-space infrastructure services, announced that Chief Executive Officer John Rood will participate in the Morgan Stanley 5th Annual Space Summit taking place on December 6, 2022, in New York City.
  • Mr. Rood will participate in the Space Infrastructure To the Moon and Back and Everything in Between panel beginning at 2:15 p.m.
  • Additionally, Mr. Rood will host meetings with institutional investors, which can be arranged through your Morgan Stanley representative.
  • Momentus Chief Executive Officer John Rood will participate in the Space Infrastructure To the Moon and Back and Everything in Between panel that will be moderated by Kristine Liwag, Aerospace and Defense Analyst, Morgan Stanley.

Isabella Rossellini's new one-woman show heads to Cold Spring Harbor Laboratory, March 4-5, 2023

Retrieved on: 
Friday, December 2, 2022
Face, Student, Human, Biomedical Research, SPRING, CSHL, Brain, Cancer, Showtime, Meeting, Hou, Communication, Neuroscience, Expression, Animal, Multimedia, Laboratory, Science, Education, Cold Spring Harbor Laboratory, Nobel Prize, Entertainment, Emotion

COLD SPRING HARBOR, N.Y., Dec. 2, 2022 /PRNewswire/ -- Humans convey a wide range of emotions through facial expressions.

Key Points: 
  • COLD SPRING HARBOR, N.Y., Dec. 2, 2022 /PRNewswire/ -- Humans convey a wide range of emotions through facial expressions.
  • That is what famed Italian actress Isabella Rossellini explores in her new witty and provocative one-woman show, Darwin's Smile , coming to Cold Spring Harbor Laboratory's (CSHL's) Grace Auditorium for a two-day run, Saturday and Sunday, March 4-5, 2023.
  • Written and performed by Rossellini, the play takes inspiration from The Expression of Emotions on Man and Animals by Charles Darwin.
  • Founded in 1890, Cold Spring Harbor Laboratory has shaped contemporary biomedical research and education with programs in cancer, neuroscience, plant biology and quantitative biology.